tiprankstipranks
Advertisement
Advertisement
Tiziana Life Sciences announces new data on nasal foralumab
PremiumThe FlyTiziana Life Sciences announces new data on nasal foralumab
2M ago
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
Premium
Company Announcements
Tiziana Life Sciences’ Intranasal Foralumab MS Study Published in Leading Neurology Journal
3M ago
Tiziana Life Sciences announces publication of intranasal foralumab results
Premium
The Fly
Tiziana Life Sciences announces publication of intranasal foralumab results
3M ago
Tiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
PremiumCompany AnnouncementsTiziana Reports Clean FDA Safety Update for Intranasal Foralumab After 37.4 Patient-Years of Exposure
4M ago
Tiziana Life Sciences files annual safety report for intranasal foralumab
Premium
The Fly
Tiziana Life Sciences files annual safety report for intranasal foralumab
4M ago
Tiziana Life Sciences Chair Boosts Stake to 36% with December Share Purchase
Premium
Company Announcements
Tiziana Life Sciences Chair Boosts Stake to 36% with December Share Purchase
4M ago
Tiziana Life Sciences CEO Increases Stake with Significant Share Purchase
PremiumCompany AnnouncementsTiziana Life Sciences CEO Increases Stake with Significant Share Purchase
4M ago
Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares
Premium
The Fly
Tiziana Life Sciences CEO Ivor Elrifi purchases 163,400 shares
4M ago
Tiziana Life Sciences Withdraws Public Offering Amid Market Conditions
Premium
Company Announcements
Tiziana Life Sciences Withdraws Public Offering Amid Market Conditions
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100